As the vaccine candidate, Covishield, being developed by Oxford University and UK pharma giant Astra Zeneca enters the Phase II and Phase III clinical trials in India, in collaboration with the Pune-based Serum Institute of India (SII), Adar Poonawalla, the CEO of SII, raised a question regarding India’s plan to …
Read More »
Gulte Movie News And Politics